About Graphite Bio, Inc. 
Graphite Bio, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 30 Schemes (9.84%)
Foreign Institutions
Held by 44 Foreign Institutions (7.28%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
5 Million
(Quarterly Results - Jun 2025)
Net Profit:
-15 Million
Pharmaceuticals & Biotechnology
USD 1,102 Million (Small Cap)
NA (Loss Making)
NA
0.00%
-1.01
-25.39%
5.34






